Heart Rhythm
Volume 6, Issue 10 , Pages 1430-1431 , October 2009

Anticoagulation, atrial fibrillation, and therapeutic international normalized ratio during catheter ablation

  • Robert Lemery, MD, FHRS, CCDS

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Robert Lemery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada, K1Y-4W7

References 

  1. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up (A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA)). Heart Rhythm. 2007;4:816–861
  2. Wazni OM, Beheiry S, Fahmy T, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116:2531–2534
  3. Asirvatham SJ. Ablation for atrial fibrillation: can we decrease thromboembolism without increasing the risk for bleeding?. Circulation. 2007;116:2517–2519
  4. Hussein AA, Martin DO, Patel D, et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm. 2009;6:1425–1429
  5. Kim SS, Hijazi ZM, Lang RM, Knight BP. The use of intracardiac echocardiography and other intracardiac imaging tools to guide noncoronary cardiac interventions. J Am Coll Cardiol. 2009;53:2117–2128
  6. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:

PII: S1547-5271(09)00809-1

doi: 10.1016/j.hrthm.2009.07.038

Heart Rhythm
Volume 6, Issue 10 , Pages 1430-1431 , October 2009

Article Tools